International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-6 doi: https://doi.org/10.5281/zenodo.14590986
Original Research Article
MAGNITUDE OF ANEMIA AND KNOWLEDGE ABOUT IRON AND FOLIC ACID SUPPLEMENTS (IFAS) AMONG ANTENATAL WOMEN, GOVT.GENENRAL HOSPITAL, KURNOOL, ANDHRA PRADESH: A CROSSSECTIONAL, DESCRIPTIVE STUDY
Published
Dec. 31, 2024
Abstract

Background: Iron and folic acid supplements are a key intervention and mandatory for all antenatal women, irrespective of their haemoglobin status, because as gestational weeks increase, nutrition alone is insufficient to meet the demands. On the other hand, the prevalence of anaemia remains persistently high, with 52% of antenatal women being anaemic, according to NFHS-5. IFAS has shown significant benefits in reducing maternal and foetal complications. Objectives: The aim of this study was to estimate the magnitude of anaemia and assess knowledge about Iron and Folic Acid Supplements (IFAS) among antenatal women. Methods: An observational, descriptive cross-sectional study was conducted among 142 antenatal women selected by convenience sampling at Government General Hospital (GGH), Kurnool. Sahli's method was used for haemoglobin estimation, and a structured questionnaire was used to assess knowledge after obtaining informed consent. Results: Out of 142 antenatal women, 45% belonged to the 18–21-year age group, 50.7% were primi’s, and 49% were multigravidas. The magnitude of anaemia among antenatal women was normal, mild, moderate 27.4%, 61.9% and 10.56% respectively. The proportion of antenatal women having good, fair, and poor knowledge about IFAS was 0.7%, 52.8%, and 46.4%, respectively. Conclusion: The study revealed that the majority of antenatal women 61.9%were anaemic, with only 27.4% having normal haemoglobin levels. Furthermore, 46.4% of the women had poor knowledge about IFAS..Hence should focus more on Information, Education and Communication activities(IEC).

Recommended Articles
Loading Image...
Volume-5, Issue-6
Citations
1711 Views
438 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved